1. Home
  2. XRTX vs ASTI Comparison

XRTX vs ASTI Comparison

Compare XRTX & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • ASTI
  • Stock Information
  • Founded
  • XRTX 2011
  • ASTI 2005
  • Country
  • XRTX Canada
  • ASTI United States
  • Employees
  • XRTX N/A
  • ASTI N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • ASTI Semiconductors
  • Sector
  • XRTX Health Care
  • ASTI Technology
  • Exchange
  • XRTX Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • XRTX 3.0M
  • ASTI 3.1M
  • IPO Year
  • XRTX N/A
  • ASTI N/A
  • Fundamental
  • Price
  • XRTX $1.08
  • ASTI $1.68
  • Analyst Decision
  • XRTX
  • ASTI
  • Analyst Count
  • XRTX 0
  • ASTI 0
  • Target Price
  • XRTX N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • XRTX 44.3K
  • ASTI 54.4K
  • Earning Date
  • XRTX 05-16-2025
  • ASTI 05-08-2025
  • Dividend Yield
  • XRTX N/A
  • ASTI N/A
  • EPS Growth
  • XRTX N/A
  • ASTI N/A
  • EPS
  • XRTX N/A
  • ASTI N/A
  • Revenue
  • XRTX N/A
  • ASTI $41,893.00
  • Revenue This Year
  • XRTX N/A
  • ASTI N/A
  • Revenue Next Year
  • XRTX N/A
  • ASTI N/A
  • P/E Ratio
  • XRTX N/A
  • ASTI N/A
  • Revenue Growth
  • XRTX N/A
  • ASTI N/A
  • 52 Week Low
  • XRTX $0.80
  • ASTI $1.17
  • 52 Week High
  • XRTX $3.24
  • ASTI $34.00
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 59.65
  • ASTI 58.20
  • Support Level
  • XRTX $0.82
  • ASTI $1.30
  • Resistance Level
  • XRTX $1.13
  • ASTI $1.70
  • Average True Range (ATR)
  • XRTX 0.10
  • ASTI 0.13
  • MACD
  • XRTX 0.03
  • ASTI 0.06
  • Stochastic Oscillator
  • XRTX 71.65
  • ASTI 96.23

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: